Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Grever MR"" wg kryterium: Autor


Tytuł :
Phase II study of flavopiridol in relapsed chronic lymphocytic leukemia demonstrating high response rates in genetically high-risk disease.
Autorzy :
Lin TS
Ruppert AS
Johnson AJ
Fischer B
Heerema NA
Andritsos LA
Blum KA
Flynn JM
Jones JA
Hu W
Moran ME
Mitchell SM
Smith LL
Wagner AJ
Raymond CA
Schaaf LJ
Phelps MA
Villalona-Calero MA
Grever MR
Byrd JC
Pokaż więcej
Źródło :
Journal of Clinical Oncology; 12/10/2009, Vol. 27 Issue 35, p6012-6018, 7p
Czasopismo naukowe
Tytuł :
Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumors.
Autorzy :
Kaumaya PT
Foy KC
Garrett J
Rawale SV
Vicari D
Thurmond JM
Lamb T
Mani A
Kane Y
Balint CR
Chalupa D
Otterson GA
Shapiro CL
Fowler JM
Grever MR
Bekaii-Saab TS
Carson WE 3rd
Kaumaya, Pravin T P
Foy, Kevin Chu
Garrett, Joan
Pokaż więcej
Źródło :
Journal of Clinical Oncology; 11/1/2009, Vol. 27 Issue 31, p5270-5277, 8p
Czasopismo naukowe
Tytuł :
Computed tomography scans do not improve the predictive power of 1996 national cancer institute sponsored working group chronic lymphocytic leukemia response criteria.
Autorzy :
Blum KA
Young D
Broering S
Lucas MS
Fischer B
Lin TS
Grever MR
Byrd JC
Blum, Kristie A
Young, Donn
Broering, Sarah
Lucas, Margaret S
Fischer, Beth
Lin, Thomas S
Grever, Michael R
Byrd, John C
Pokaż więcej
Źródło :
Journal of Clinical Oncology; 12/10/2007, Vol. 25 Issue 35, p5624-5629, 6p
Czasopismo naukowe
Tytuł :
BTK -Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia.
Autorzy :
Woyach JA; All authors: The Ohio State University, Columbus, OH.
Ruppert AS; All authors: The Ohio State University, Columbus, OH.
Guinn D; All authors: The Ohio State University, Columbus, OH.
Lehman A; All authors: The Ohio State University, Columbus, OH.
Blachly JS; All authors: The Ohio State University, Columbus, OH.
Lozanski A; All authors: The Ohio State University, Columbus, OH.
Heerema NA; All authors: The Ohio State University, Columbus, OH.
Zhao W; All authors: The Ohio State University, Columbus, OH.
Coleman J; All authors: The Ohio State University, Columbus, OH.
Jones D; All authors: The Ohio State University, Columbus, OH.
Abruzzo L; All authors: The Ohio State University, Columbus, OH.
Gordon A; All authors: The Ohio State University, Columbus, OH.
Mantel R; All authors: The Ohio State University, Columbus, OH.
Smith LL; All authors: The Ohio State University, Columbus, OH.
McWhorter S; All authors: The Ohio State University, Columbus, OH.
Davis M; All authors: The Ohio State University, Columbus, OH.
Doong TJ; All authors: The Ohio State University, Columbus, OH.
Ny F; All authors: The Ohio State University, Columbus, OH.
Lucas M; All authors: The Ohio State University, Columbus, OH.
Chase W; All authors: The Ohio State University, Columbus, OH.
Jones JA; All authors: The Ohio State University, Columbus, OH.
Flynn JM; All authors: The Ohio State University, Columbus, OH.
Maddocks K; All authors: The Ohio State University, Columbus, OH.
Rogers K; All authors: The Ohio State University, Columbus, OH.
Jaglowski S; All authors: The Ohio State University, Columbus, OH.
Andritsos LA; All authors: The Ohio State University, Columbus, OH.
Awan FT; All authors: The Ohio State University, Columbus, OH.
Blum KA; All authors: The Ohio State University, Columbus, OH.
Grever MR; All authors: The Ohio State University, Columbus, OH.
Lozanski G; All authors: The Ohio State University, Columbus, OH.
Johnson AJ; All authors: The Ohio State University, Columbus, OH.
Byrd JC; All authors: The Ohio State University, Columbus, OH.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2017 May 01; Vol. 35 (13), pp. 1437-1443. Date of Electronic Publication: 2017 Feb 13.
Typ publikacji :
Clinical Trial, Phase I; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell/*enzymology
Protein-Tyrosine Kinases/*genetics
Pyrazoles/*therapeutic use
Pyrimidines/*therapeutic use
Adult ; Agammaglobulinaemia Tyrosine Kinase ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal, Humanized ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Drug Resistance, Neoplasm ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/genetics ; Male ; Middle Aged ; Phospholipase C gamma/genetics ; Protein-Tyrosine Kinases/metabolism ; Pyrazoles/administration & dosage ; Pyrazoles/pharmacology ; Pyrimidines/administration & dosage ; Pyrimidines/pharmacology
Czasopismo naukowe
Tytuł :
Modern strategies for hairy cell leukemia.
Autorzy :
Grever MR; The Ohio State University Medical Center, Columbus, OH, USA. michael.grever@osumc.edu
Lozanski G
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2011 Feb 10; Vol. 29 (5), pp. 583-90. Date of Electronic Publication: 2011 Jan 10.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Leukemia, Hairy Cell/*drug therapy
Humans ; Kidney/physiopathology ; Leukemia, Hairy Cell/diagnosis ; Leukemia, Hairy Cell/physiopathology ; Neoplasm, Residual ; Recurrence
Czasopismo naukowe
Tytuł :
Dose escalation of lenalidomide in relapsed or refractory acute leukemias.
Autorzy :
Blum W; Division of Hematology, The Ohio State University and The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA. />Klisovic RB
Becker H
Yang X
Rozewski DM
Phelps MA
Garzon R
Walker A
Chandler JC
Whitman SP
Curfman J
Liu S
Schaaf L
Mickle J
Kefauver C
Devine SM
Grever MR
Marcucci G
Byrd JC
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2010 Nov 20; Vol. 28 (33), pp. 4919-25. Date of Electronic Publication: 2010 Oct 18.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Leukemia, Myeloid, Acute/*drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy
Thalidomide/*analogs & derivatives
Adult ; Aged ; Aged, 80 and over ; Antigens, CD/analysis ; Antigens, Differentiation, Myelomonocytic/analysis ; Humans ; Lenalidomide ; Middle Aged ; Recurrence ; Sialic Acid Binding Ig-like Lectin 3 ; Thalidomide/adverse effects ; Thalidomide/therapeutic use
Czasopismo naukowe
Tytuł :
Flavopiridol, fludarabine, and rituximab in mantle cell lymphoma and indolent B-cell lymphoproliferative disorders.
Autorzy :
Lin TS; Division of Hematology and Oncology, The Ohio State University, Center for Biostatistics, The Ohio State University, Columbus, OH 43210, USA.
Blum KA
Fischer DB
Mitchell SM
Ruppert AS
Porcu P
Kraut EH
Baiocchi RA
Moran ME
Johnson AJ
Schaaf LJ
Grever MR
Byrd JC
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2010 Jan 20; Vol. 28 (3), pp. 418-23. Date of Electronic Publication: 2009 Dec 14.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Lymphoma, Mantle-Cell/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal, Murine-Derived ; B-Lymphocytes ; Female ; Flavonoids/administration & dosage ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy ; Lymphoma, B-Cell/drug therapy ; Lymphoproliferative Disorders/drug therapy ; Male ; Middle Aged ; Piperidines/administration & dosage ; Rituximab ; Vidarabine/administration & dosage ; Vidarabine/analogs & derivatives
Czasopismo naukowe
Tytuł :
Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997.
Autorzy :
Grever MR; Eastern Cooperative Oncology Group, Division of Hematology-Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA. michael.grever@osumc.edu
Lucas DM
Dewald GW
Neuberg DS
Reed JC
Kitada S
Flinn IW
Tallman MS
Appelbaum FR
Larson RA
Paietta E
Jelinek DF
Gribben JG
Byrd JC
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2007 Mar 01; Vol. 25 (7), pp. 799-804. Date of Electronic Publication: 2007 Feb 05.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms :
Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy
ADP-ribosyl Cyclase 1/analysis ; Adult ; Aged ; Aged, 80 and over ; Apoptosis ; Chromosome Aberrations ; Female ; Genes, p53 ; Humans ; Immunoglobulin Heavy Chains/genetics ; Immunoglobulin Variable Region/genetics ; Leukemia, Lymphocytic, Chronic, B-Cell/genetics ; Leukemia, Lymphocytic, Chronic, B-Cell/mortality ; Male ; Middle Aged ; Mutation ; Prospective Studies ; ZAP-70 Protein-Tyrosine Kinase/analysis
Czasopismo naukowe
Tytuł :
Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997.
Autorzy :
Flinn IW; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD, USA. />Neuberg DS
Grever MR
Dewald GW
Bennett JM
Paietta EM
Hussein MA
Appelbaum FR
Larson RA
Moore DF Jr
Tallman MS
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2007 Mar 01; Vol. 25 (7), pp. 793-8. Date of Electronic Publication: 2007 Feb 05.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy
Vidarabine/*analogs & derivatives
Adult ; Aged ; Aged, 80 and over ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/adverse effects ; Female ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/mortality ; Logistic Models ; Male ; Middle Aged ; Neoplasms, Second Primary/epidemiology ; Prognosis ; Vidarabine/administration & dosage ; Vidarabine/adverse effects ; Vidarabine/therapeutic use
Czasopismo naukowe
Tytuł :
Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy.
Autorzy :
Byrd JC; Division of Hematology-Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA. />Gribben JG
Peterson BL
Grever MR
Lozanski G
Lucas DM
Lampson B
Larson RA
Caligiuri MA
Heerema NA
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2006 Jan 20; Vol. 24 (3), pp. 437-43. Date of Electronic Publication: 2005 Dec 12.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Gene Deletion*
Mutation*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Genes, Immunoglobulin Heavy Chain/*genetics
Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell/*genetics
Tumor Suppressor Protein p53/*genetics
Adult ; Aged ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal, Murine-Derived ; Chromosomes, Human, Pair 11 ; Chromosomes, Human, Pair 17 ; Clinical Trials, Phase II as Topic ; Disease Progression ; Disease-Free Survival ; Female ; Genetic Predisposition to Disease ; Humans ; Immunologic Factors/administration & dosage ; Leukemia, Lymphocytic, Chronic, B-Cell/immunology ; Male ; Middle Aged ; Predictive Value of Tests ; Prognosis ; Randomized Controlled Trials as Topic ; Risk Assessment ; Risk Factors ; Rituximab ; Vidarabine/administration & dosage ; Vidarabine/analogs & derivatives
Czasopismo naukowe
Tytuł :
TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia.
Autorzy :
Raval A; Division of Human Cancer Genetics, Department of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Lucas DM
Matkovic JJ
Bennett KL
Liyanarachchi S
Young DC
Rassenti L
Kipps TJ
Grever MR
Byrd JC
Plass C
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2005 Jun 10; Vol. 23 (17), pp. 3877-85. Date of Electronic Publication: 2005 Apr 04.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
DNA Methylation*
Gene Expression Regulation, Leukemic*
Somatic Hypermutation, Immunoglobulin*
Azacitidine/*analogs & derivatives
Immunoglobulin Heavy Chains/*genetics
Immunoglobulin Variable Region/*genetics
Leukemia, Lymphocytic, Chronic, B-Cell/*genetics
Repressor Proteins/*genetics
Transcription Factors/*genetics
Antimetabolites, Antineoplastic/therapeutic use ; Azacitidine/therapeutic use ; B-Lymphocytes/pathology ; DNA Modification Methylases/antagonists & inhibitors ; Decitabine ; Gene Expression Regulation, Neoplastic ; Helix-Loop-Helix Motifs ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy ; Prognosis ; Promoter Regions, Genetic ; Treatment Outcome ; Twist-Related Protein 1
Czasopismo naukowe
Tytuł :
Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity.
Autorzy :
Marcucci G; Division of Hematology-Oncology, The Comprehensive Cancer Center, The Ohio State University, 433A Starling-Loving Hall, 320 West 10th Ave, Columbus, OH 43210, USA. />Stock W
Dai G
Klisovic RB
Liu S
Klisovic MI
Blum W
Kefauver C
Sher DA
Green M
Moran M
Maharry K
Novick S
Bloomfield CD
Zwiebel JA
Larson RA
Grever MR
Chan KK
Byrd JC
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2005 May 20; Vol. 23 (15), pp. 3404-11. Date of Electronic Publication: 2005 Apr 11.
Typ publikacji :
Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Remission Induction*
Daunorubicin/*administration & dosage
Leukemia, Myeloid, Acute/*drug therapy
Proto-Oncogene Proteins c-bcl-2/*drug effects
Thionucleotides/*administration & dosage
Thionucleotides/*pharmacokinetics
Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Biological Availability ; Daunorubicin/adverse effects ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Female ; Humans ; Leukemia, Myeloid, Acute/mortality ; Leukemia, Myeloid, Acute/pathology ; Male ; Maximum Tolerated Dose ; Middle Aged ; Neoplasm Staging ; Oligonucleotides, Antisense/administration & dosage ; Oligonucleotides, Antisense/pharmacokinetics ; Probability ; Prognosis ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Risk Assessment ; Statistics, Nonparametric ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Pentostatin in steroid-refractory acute graft-versus-host disease.
Autorzy :
Bolaños-Meade J; Division of Hematologic Malignancies, Department of Oncology, Johns Hopkins Univeristy, Baltimore, MD 21231, USA.
Jacobsohn DA
Margolis J
Ogden A
Wientjes MG
Byrd JC
Lucas DM
Anders V
Phelps M
Grever MR
Vogelsang GB
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2005 Apr 20; Vol. 23 (12), pp. 2661-8.
Typ publikacji :
Clinical Trial; Clinical Trial, Phase I; Historical Article; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Graft vs Host Disease/*drug therapy
Immunosuppressive Agents/*therapeutic use
Pentostatin/*therapeutic use
Acute Disease ; Adolescent ; Adult ; Apoptosis ; Bone Marrow Transplantation ; Child ; Child, Preschool ; Dose-Response Relationship, Drug ; Female ; Hematologic Neoplasms/therapy ; History, 16th Century ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/adverse effects ; Infant ; Infusions, Intravenous ; Lymphocytes ; Male ; Maximum Tolerated Dose ; Middle Aged ; Pentostatin/administration & dosage ; Pentostatin/adverse effects ; Transplantation, Homologous ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity.
Autorzy :
Byrd JC; Division of Hematology-Oncology, Department of Medicine and the Department of Clinical Investigation, Walter Reed Army Medical Center, Washington, DC, USA. />Murphy T
Howard RS
Lucas MS
Goodrich A
Park K
Pearson M
Waselenko JK
Ling G
Grever MR
Grillo-Lopez AJ
Rosenberg J
Kunkel L
Flinn IW
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2001 Apr 15; Vol. 19 (8), pp. 2153-64.
Typ publikacji :
Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Monoclonal/*administration & dosage
Antineoplastic Agents/*administration & dosage
Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy
Aged ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal, Murine-Derived ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/pharmacology ; Cytokines/pharmacology ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Dyspnea/chemically induced ; Female ; Humans ; Hypotension/chemically induced ; Hypoxia/chemically induced ; Infusions, Intravenous ; Leukemia, Lymphocytic, Chronic, B-Cell/pathology ; Male ; Middle Aged ; Rituximab ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Immunosuppressive effects of pentostatin.
Autorzy :
Kraut EH; Department of Internal Medicine, Ohio State University, Columbus 43210.
Neff JC
Bouroncle BA
Gochnour D
Grever MR
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 1990 May; Vol. 8 (5), pp. 848-55.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Immune Tolerance/*drug effects
Leukemia, Hairy Cell/*immunology
Pentostatin/*therapeutic use
Antibody-Dependent Cell Cytotoxicity/drug effects ; B-Lymphocytes ; Humans ; Killer Cells, Natural/drug effects ; Killer Cells, Natural/immunology ; Leukemia, Hairy Cell/drug therapy ; Leukocyte Count/drug effects ; Leukopenia/chemically induced ; Lymphocyte Activation/drug effects ; Neoplasms/drug therapy ; Neoplasms/immunology ; Pentostatin/adverse effects ; Prospective Studies ; T-Lymphocytes
Czasopismo naukowe
Tytuł :
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.
Autorzy :
Cheson BD; Clinical Investigations Branch, National Cancer Institute, Bethesda, MD 20892.
Cassileth PA
Head DR
Schiffer CA
Bennett JM
Bloomfield CD
Brunning R
Gale RP
Grever MR
Keating MJ
et. al.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 1990 May; Vol. 8 (5), pp. 813-9.
Typ publikacji :
Consensus Development Conference; Consensus Development Conference, NIH; Journal Article; Review
MeSH Terms :
Leukemia, Myeloid, Acute/*diagnosis
Antibodies, Monoclonal ; Biopsy ; Blood Cell Count ; Bone Marrow/pathology ; Chromosome Aberrations ; Humans ; Karyotyping ; Leukemia, Myeloid, Acute/classification ; Leukemia, Myeloid, Acute/therapy ; Remission Induction ; United States
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies